Cargando…
Risk Factors for Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Community-Onset Bloodstream Infection: Impact on Long-Term Care Hospitals in Korea
BACKGROUND: The prevalence of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in the community has increased worldwide due to multifactorial reasons. ESBL-EC bloodstream infection (BSI) complicates the decision for proper antimicrobial administration. In this multicenter study, we...
Autores principales: | Baek, Yae Jee, Kim, Young Ah, Kim, Dokyun, Shin, Jong Hee, Uh, Young, Shin, Kyeong Seob, Shin, Jeong Hwan, Jeong, Seok Hoon, Lee, Geun Woo, Lee, Eun Ji, Kim, Dong-Sook, Park, Yoon Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Laboratory Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041596/ https://www.ncbi.nlm.nih.gov/pubmed/33824233 http://dx.doi.org/10.3343/alm.2021.41.5.455 |
Ejemplares similares
-
476. Risk Factors of Community-Onset Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Bacteremia in South Korea Using National Health Insurance Claims Data
por: Lee, Yongseop, et al.
Publicado: (2019) -
Impact of host-pathogen-treatment tripartite components on early mortality of patients with Escherichia coli bloodstream infection: Prospective observational study
por: Yoon, Eun-Jeong, et al.
Publicado: (2018) -
Counter Clinical Prognoses of Patients With Bloodstream Infections Between Causative Acinetobacter baumannii Clones ST191 and ST451 Belonging to the International Clonal Lineage II
por: Yoon, Eun-Jeong, et al.
Publicado: (2019) -
Major Bloodstream Infection-Causing Bacterial Pathogens and Their Antimicrobial Resistance in South Korea, 2017–2019: Phase I Report From Kor-GLASS
por: Kim, Dokyun, et al.
Publicado: (2022) -
Characteristics of Escherichia coli Urine Isolates and Risk Factors for Secondary Bloodstream Infections in Patients with Urinary Tract Infections
por: Choi, Hyeon Jin, et al.
Publicado: (2022)